Keros Therapeutics
KROS
#7004
Rank
NZ$0.71 B
Marketcap
$17.67
Share price
-0.60%
Change (1 day)
-83.21%
Change (1 year)

Revenue for Keros Therapeutics (KROS)

Revenue in 2024 (TTM): NZ$6.2 Million

According to Keros Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$6.32 Million. an increase over the revenue in the year 2023 that were of NZ$0.23 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Keros Therapeutics from 2019 to 2024

Annual revenue

Year Revenue Change
2024 NZ$6.29 M2536.25%
2023 NZ$0.23 M
2022 N/A-100%
2021 NZ$29.42 M
2020 N/A-100%
2019 NZ$14.84 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA